about
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.
Read More
1.30
-0.02
(-1.52%)
35,360
XNAS Volume
XNAS 20 Feb, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Bearish
BeyondSpring Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..